Metabolic and bariatric surgery compared to intensive nonsurgical therapy in adolescents with severe obesity (AMOS2): A multicenter, randomized, controlled trial in Sweden

被引：0
|
作者：
Teoule, Patrick [1 ]
Blank, Susanne [1 ]
Boettcher, Michael [2 ]
Reissfelder, Christoph [1 ]
Otto, Mirko [1 ]
机构：
[1] Heidelberg Univ, Chirurg Klin, Med Fak Mannheim, Univ Med Mannheim, Mannheim, Germany
[2] Heidelberg Univ, Univ Med Mannheim, Klin Kinder & Jugendchirurg, Medizin Fak Mannheim, Heidelberg, Germany
来源：
CHIRURGIE | 2023年 / 94卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1039 / 1040
页数：2
相关论文
共 37 条
  • [31] Four-week omega-3 polyunsaturated fatty acids supplementation for liver left lateral section volume reduction in individuals with morbid obesity undergoing bariatric surgery: A double blind, multicenter, randomized placebo-controlled trial
    Iannelli, Antonio
    Fontas, Eric
    Grec, Laurence
    Nocca, David
    Robert, Maud
    Schiavo, Luigi
    Schneck, Anne-Sophie
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 101
  • [32] Local Consolidative Therapy (LCT) Improves Overall Survival (OS) Compared to Maintenance Therapy/Observation in Oligometastatic Non-Small Cell Lung Cancer (NSCLC): Final Results of a Multicenter, Randomized, Controlled Phase 2 Trial
    Gomez, D. R.
    Tang, C.
    Zhang, J.
    Blumenschein, G. R.
    Hernandez, M.
    Lee, J. J.
    Ye, R.
    Camidge, D. R.
    Skoulidis, F.
    Doebele, R.
    Gaspar, L. E.
    Gibbons, D. L.
    Karam, J.
    Kavanagh, B. D.
    Palma, D. A.
    Louie, A. V.
    Tsao, A.
    Sepesi, B.
    Swisher, S. G.
    Heymach, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (05): : 1604 - 1604
  • [33] Flexible intensive versus conventional insulin therapy in insulin-naive adults with type 2 diabetes -: An open-label, randomized, controlled, crossover clinical trial of metabolic control and patient preference
    Kloos, Christof
    Saemann, Alexander
    Lehmann, Thomas
    Braun, Anke
    Heckmann, Barbara
    Mueller, Ulrich A.
    DIABETES CARE, 2007, 30 (12) : 3031 - 3032
  • [34] CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial
    Cai Ming-Ci
    Cheng Shu
    Wang Xin
    Hu Jian-Da
    Song Yong-Ping
    Huang Yao-Hui
    Yan Zi-Xun
    Jiang Yu-Jie
    Fang Xiao-Sheng
    Zheng Xiao-Yun
    Dong Li-Hua
    Ji Meng-Meng
    Wang Li
    Xu Peng-Peng
    Zhao Wei-Li
    GENOME MEDICINE, 2020, 12 (01)
  • [35] CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial
    Ming-Ci Cai
    Shu Cheng
    Xin Wang
    Jian-Da Hu
    Yong-Ping Song
    Yao-Hui Huang
    Zi-Xun Yan
    Yu-Jie Jiang
    Xiao-Sheng Fang
    Xiao-Yun Zheng
    Li-Hua Dong
    Meng-Meng Ji
    Li Wang
    Peng-Peng Xu
    Wei-Li Zhao
    Genome Medicine, 12
  • [36] Basal Insulin Regimen vs. Twice Daily Premix Insulin Regimen after Short -Term Intensive Insulin Therapy (SIT) in Patients with Type 2 Diabetes (T2D): A Multicenter, Open-Label Randomized Controlled Trial
    Mu, Yiming
    Guo, Lixin
    Wan, Hailong
    Wang, Junfen
    Xu, Binhua
    Wang, Guoping
    Jiang, Chengxia
    Liang, Li
    Feng, Wei
    Liu, Jingcheng
    Zhang, Xia
    Cui, Nan
    Yin, Huiqiu
    DIABETES, 2021, 70
  • [37] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial
    Yokoh, Hidetaka
    Kobayashi, Kazuki
    Sato, Yasunori
    Takemoto, Minoru
    Uchida, Daigaku
    Kanatsuka, Azuma
    Kuribayashi, Nobuichi
    Terano, Takashi
    Hashimoto, Naotake
    Sakurai, Kenichi
    Hanaoka, Hideki
    Ishikawa, Ko
    Onishi, Shunichiro
    Yokote, Koutaro
    JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (02) : 182 - 191
1234